Investing
Horizon Pharma, TherapeuticsMD Dive into Monday's 52-Week Low Club
Published:
Last Updated:
May 8, 2017: Here are four stocks trading with relatively heavy volume among 93 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq decliners led advancers by about 4 to 3.
Horizon Pharma PLC (NASDAQ: HZNP) dropped nearly 36% Monday to post a new 52-week low of $10.02 after closing at $15.58 on Friday. The stock’s 52-week high is $23.44. Volume of nearly 32 million was about 15 times the daily average of around 2.7 million shares traded. The company missed on first-quarter profits and revenues and then lowered guidance. A deadly brew.
TherapeuticsMD Inc. (NYSEMKT: TXMD) posted a new 52-week low of $3.50 on Monday, down about 25% compared with Friday’s closing price of $4.67. The stock’s 52-week high is $9.29. Volume totaled around nearly 12 million shares, approaching 4 times the daily average of 3.3 million. The company announced that the FDA had rejected an application to market the company’s TX-004HR drug designed to treat vaginal pain.
DDR Corp. (NYSE: DDR) dropped about 6.3% Monday to post a new 52-week low of $9.27 after closing Friday at $9.89. The 52-week high is $19.92. Volume of around 5.4 million shares was less than 10% lower than the daily average of around 5.8 million. The company had no specific news.
Cobalt International Energy Inc. (NYSE: CIE) dropped about 16% Monday to post a new 52-week low of $0.26 after closing at $0.31 on Friday. The stock’s 52-week high is $2.86. Volume was less than half the daily average of around 10.3 million shares. The company reported a larger-than-expected loss this morning.
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.